Our study consistently suggested that UGT1A10, FTCD, and XDH were involved in “drug metabolism or response to drug” in PC, but their specific roles in metabolic reprogramming and chemoresistance in PC still remain to be studied. This evidence concerns the gene FTCD and pachyonychia congenita.